SAGE
SAGE Therapeutics Inc
Price:  
7.18 
USD
Volume:  
1,993,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Relative Valuation

-3299.5%
Upside

As of 2025-02-19, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (229.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.18 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -3299.5%.

The range of the Relative Valuation is (193.95) - (264.72) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.8x - 46.8x 38.4x
Forward P/E multiples 26.2x - 40.6x 32.1x
Fair Price (193.95) - (264.72) (229.72)
Upside -2801.2% - -3786.9% -3299.5%
7.18 USD
Stock Price
(229.72) USD
Fair Price

SAGE Relative Valuation - Historical P/E Data

Date P/E
2025-02-18 -1.10
2025-02-14 -1.10
2025-02-13 -1.10
2025-02-12 -1.10
2025-02-11 -1.10
2025-02-10 -1.11
2025-02-07 -1.11
2025-02-06 -1.12
2025-02-05 -1.11
2025-02-04 -1.11
2025-02-03 -1.11
2025-01-31 -1.11
2025-01-30 -1.13
2025-01-29 -1.12
2025-01-28 -1.13
2025-01-27 -1.14
2025-01-24 -1.09
2025-01-23 -1.08
2025-01-22 -1.08
2025-01-21 -1.06
2025-01-17 -1.09
2025-01-16 -1.07
2025-01-15 -1.11
2025-01-14 -1.14
2025-01-13 -1.15
2025-01-10 -0.85
2025-01-08 -0.90
2025-01-07 -0.92
2025-01-06 -0.95
2025-01-03 -0.94
2025-01-02 -0.89
2024-12-31 -0.83
2024-12-30 -0.83
2024-12-27 -0.85
2024-12-26 -0.88
2024-12-24 -0.84
2024-12-23 -0.83
2024-12-20 -0.86
2024-12-19 -0.77
2024-12-18 -0.77
2024-12-17 -0.81
2024-12-16 -0.82
2024-12-13 -0.83
2024-12-12 -0.87
2024-12-11 -0.90
2024-12-10 -0.85
2024-12-09 -0.85
2024-12-06 -0.86
2024-12-05 -0.86
2024-12-04 -0.86